Skip to content Skip to footer
Subscribe Now
VIEWPOINTS_Roy Maute_2024
VIEWPOINTS

Macrophage Checkpoint Therapy: Roy Maute from Pheast Therapeutics in a Riveting Conversation with PharmaShots

Shots:  Recently Pheast Therapeutics shared the preclinical data for PHST001, an anti-CD24 macrophage checkpoint inhibitor at the 20th Annual PEGS Boston Summit  Today, at PharmaShots, we had a dialogue exchange with Roy Maute, Cofounder and CEO of Pheast Therapeutics  Pheast Therapeutics currently plans to initiate a clinical trial in H1’25  Saurabh: Can you walk me…
June 26, 2024

Read more

VIEWPOINTS_Lev Becker_2024
VIEWPOINTS

Onchilles Pharma at AACR 2024: Lev Becker in a Stimulating Conversation with PharmaShots

Shots:  Recently, Onchilles Pharma unveiled findings from the late-stage preclinical data of its two candidates: N17350 and N17465  Today at PharmaShots, we had an engaging dialogue exchange with Lev Becker, Associate Professor, University of Chicago and Cofounder, Onchilles Pharma  Lev highlights the unique novel mechanism that Onchilles Pharma leverages to treat a wide range of…
June 19, 2024

Read more